ReadCrysta
Latest round
- Angel
Last raised
- Oct 2020
Total raised
- Undisclosed
Investors
- 1
About ReadCrysta
Established in 2019 and based in Shenzhen, China, ReadCrysta is a pharmaceutical company that developed the technology of Microcrystalline Electron Diffraction (MicroED) and platform of artificial intelligence drug discovery. It has more than 30 million yuan experimental equipment, including cryo-transmission electron microscopy, protein expression and purification crystallization, structural biology. The founding team is from the MicroED Technology Invention Group of Stockholm University, Sweden. This technology was selected as one of the top ten global technological breakthroughs in science magazine in 2018. It awarded the third place in Zhichuang Cup Biomedical Group in China. It provides the technology of structural biology and pharmaceutical solid state research that used in the filed of molecule drug structure analysis, peptide structure analysis and development, new vaccine design, enzyme engineering design. Structural biology includes MicroED, cryo-electron microscopy single particle (Cryo-EM SPA), X-ray diffraction. Pharmaceutical solid state research includes single crystal cultivation, crystal type screening, raw material preparation research.
Who invested in ReadCrysta
1 investor across 1 round
See all investors in ReadCrysta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Oct 22, 2020
Amount
Undisclosed
Investors
Questions about ReadCrysta
Who invested in ReadCrysta?
ReadCrysta has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ReadCrysta raised?
ReadCrysta has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ReadCrysta last raise money?
ReadCrysta's most recent round on record is a Angel, in Oct 2020.
What does ReadCrysta do?
Established in 2019 and based in Shenzhen, China, ReadCrysta is a pharmaceutical company that developed the technology of Microcrystalline Electron Diffraction (MicroED) and platform of artificial intelligence drug discovery.
Where is ReadCrysta headquartered?
ReadCrysta is headquartered in Shenzhen, China.
Which VCs invest in companies like ReadCrysta?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at ReadCrysta's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like ReadCrysta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.